Vertex Share Price

Vertex Share Price

NASDAQ: VRTX | Large Cap | Healthcare
$520.56
-$15.62 (-2.91%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Vertex Stock Performance

Open
$535.44
Prev. Close
$536.18
Circuit Range
N/A
Day Range
$517.82 - $537.14
Year Range
$412.60 - $568.39
Volume
52,133
Average Traded
$523.22

Vertex Share Price Today

As of 20 November 2026, Vertex Pharmaceuticals Incorporated's share price is $520.56. The stock opened at $535.44, compared to its previous close of $536.18. During today's trading session, Vertex Pharmaceuticals Incorporated's share price traded between $517.82 and $537.14, with an average price of $527.48. Over the past 52 weeks, the stock has recorded a high of $568.39 and a low of $412.60. In terms of performance, Vertex Pharmaceuticals Incorporated's share price has risen by 16.34% over the last six months and is up 20.12% on a year-on-year basis.

Vertex Share Price Chart

Line chart of the Vertex price trend over the selected period. The price fell overall, ranging from 531.20 to 541.66, ending at 536.55.
$517.82$537.14
L
Show Current Price
H

Vertex Stock Fundamentals & Key Indicators

Market Cap
$133.11B
PE Ratio (TTM)
34.21
Dividend Yield
0.00%
EPS (TTM)
$15.68
Revenue (TTM)
$12.00B
Return On Equity (TTM)
19.02%
Profit Margin
32.92%
Debt to Equity
0.22
Quarterly Earnings Growth YoY
-45.13%

Vertex Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3190.00$2986.90$3333.90$3440.80
Net Profit$1191.10$1031.40$1099.80$653.60
Net Profit Margin37.34%34.53%32.99%19.00%
Income ChangeN/A-13.41%6.63%-40.57%

Vertex Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$8.93$9.87$11.02$12.00
Net Profit$3.32$3.62-$0.54$3.95
Net Profit Margin37.18%36.68%-4.90%32.92%
Income ChangeN/A9.04%-114.92%831.48%

Vertex Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets14.4412.948.594.92
Current Assets11.29.614.1413.23
Total Assets25.6422.5322.7318.15
Non Current Liabilities3.122.561.61.5
Current Liabilities3.863.563.552.74
Total Liabilities6.986.125.154.24
Shareholders' Equity18.6716.4117.5813.91

Vertex Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating3,631.4-492.63,537.34,129.9
Investing-945.4-3,770.0-3,141.7-321.1
Financing-2,261.3-1,494.9-562.2-67.7

About Vertex

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

Vertex Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$559.50
$520.73
-6.93%
Oct 2026
$523.51
$559.48
+6.94%
Sep 2026
$549.24
$523.18
-4.42%
Aug 2026
$483.35
$547.38
+14.75%
Jul 2026
$501.90
$477.02
-3.92%
Jun 2026
$440.50
$496.46
+10.96%
May 2026
$425.07
$447.44
+4.68%
Apr 2026
$450.98
$427.45
-4.26%
Mar 2026
$495.52
$446.48
-10.14%
Feb 2026
$467.99
$496.83
+5.72%
Jan 2026
$453.32
$469.95
+3.64%
Dec 2025
$432.72
$453.46
+4.64%

Vertex Share Price FAQs